Literature DB >> 8383062

Cocaine-like discriminative stimulus properties of the delta-selective opioid receptor agonist, [D-Pen2,L-Pen5]enkephalin, in the rat.

M Ukai1, E Mori, T Kameyama.   

Abstract

The delta-selective opioid receptor agonist, [D-Pen2,L-Pen5]enkephalin (DPLPE) (10 micrograms i.c.v.), fully generalized to cocaine cue in the rat trained to discriminate 10 mg/kg of cocaine from vehicle. The cocaine-like discriminative stimulus effects of DPLPE were almost completely reversed by naltrindole (56 micrograms i.c.v.), a delta-selective opioid receptor antagonist. In contrast, the mu-selective opioid receptor agonist [D-Ala2,NMePhe4,Gly-ol]enkephalin (DAMGO) (0.03-0.3 micrograms i.c.v.) failed to generalize to cocaine cue. These results suggest that the discriminative stimulus effects of cocaine are mediated through the activation of delta-opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383062     DOI: 10.1016/0014-2999(93)90696-f

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Effects of the selective delta opioid agonist SNC80 on cocaine- and food-maintained responding in rhesus monkeys.

Authors:  Gail Pereira Do Carmo; Nancy K Mello; Kenner C Rice; John E Folk; S Stevens Negus
Journal:  Eur J Pharmacol       Date:  2006-07-05       Impact factor: 4.432

2.  Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin) in pigeons.

Authors:  D C Jewett; H I Mosberg; J H Woods
Journal:  Psychopharmacology (Berl)       Date:  1996-10       Impact factor: 4.530

3.  The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum.

Authors:  Kelly E Bosse; Emily M Jutkiewicz; Margaret E Gnegy; John R Traynor
Journal:  Neuropharmacology       Date:  2008-06-18       Impact factor: 5.250

Review 4.  Endogenous opiates: 1993.

Authors:  G A Olson; R D Olson; A J Kastin
Journal:  Peptides       Date:  1994       Impact factor: 3.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.